News

Born with congenital heart disease, Christin Murphy, 41, was familiar with cardiology appointments, stress tests, and surgeries.

Chandler DeBolt needed immediate attention but had extremely limited options before his family was referred to the Adult Congenital Heart Disease program at Saint Luke’s Mid America Heart Institute in Kansas City.

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.

Dr. Mary Mitchell, chief of breast radiology at Saint Luke's, talks to KSHB about what dense breast tissue is and how it impacts your risk of developing breast cancer.

Largest systematic study of atherosclerosis in ancient human remains suggests innate human predisposition to heart disease.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

This year, Michelle almost skipped her preventive screening, but instead of skipping, she chose to get her first 3D mammogram. And like many women, she wasn’t aware that it was now covered by insurance.

We’re talking about how younger women and men can monitor for breast cancer and recent updates in screening guidelines.